Search This Blog

Healthcare Market Explores

Posts

​According to the latest report published by Credence Research, Inc. “Angioedema Treatment Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the angioedema market was valued at USD 895.4 Mn in 2015, and is expected to reach USD 1,658.0 Mn by 2022, expanding at a CAGR of 9.2% from 2016 to 2022. Browse the full report Angioedema Treatment Market Growth, Future Prospects and Competitive Analysis, 2016-2022 at http://www.credenceresearch.com/report/angioedema-treatment-market Market Insights
Growth in healthcare investments, prevalence of angioedema and growing high-risk geriatric population are the major factors driving the global market growth for angioedema treatment. North America is the largest regional market at a market share of over 41% in 2015, and the dominance of this region is anticipated to continue through 2022. Rising incidence of angioedema and high awareness about treatment and the management of angioedema together drive the North America angioedema mar…

​The latest market report published by Credence Research, Inc. “Contract Research Organization Services Market, By Service Type, Research Type and Client Type - Growth, Future Prospects and Competitive Analysis, 2016 - 2023,” the global contract research organization (CRO) services market was valued at US$ 25.9 Mn in 2015, and is expected to reach US$ 44.8 Mn by 2023, expanding at a CAGR of 7.1% from 2016 to 2023. Market Insights
The global CRO market has witnessed a significant rise in strategic mergers and collaborations among CRO vendors. Such growth strategies are focused at augmenting their service portfolio or develop their niche in select countries. Large scale pharmaceutical companies in countries such as North America, Europe and Asia Pacific are increasingly indulging in CRO activities due to availability of large pool of trial eligible patients, desire to reduce costs and growing need to focus on core competencies. With further expansion and consolidation activities taking …

​According to a new market research report published by Credence Research “Positive Patient Identification (PPID) Market(Component: Scanning Equipment and Software & Services; Deployment Model: Web-based and Cloud-based) - Growth, Future Prospects and Competitive Analysis, 2016 - 2023”, the global positive patient identification market is estimated to reach US$ 1.65 Bn by 2023. Market Insights
Positive patient identification refers to a combination of hardware and software solutions designed for identifying a patient’s details so as to ensure correct medication is provided to the same. The most significant factor driving the market growth is the rising expenditure over healthcare IT and other automation systems designed for carrying seamless processes in healthcare organizations. Another major factor fueling the market growth is the growing instances of patient misidentification leading to fatal losses to the patients along with economic loss. Browse the full report at http://www.c…

According to the latest report published by Credence Research, Inc. “Telehealth Market Growth, Future Prospects and Competitive Analysis, 2016 - 2022,” the telehealth market size was valued at USD 2,193.1 Mn in 2015, and is expected to reach USD 10,467.0 Mn by 2022, expanding at a CAGR of 24.7% from 2016 to 2022. Market Insights
Phenomenal rise in the aging and chronically ill population, shortage of specialized medical practitioners in North America and some other parts of the world, growing need for remote patient monitoring and rapid technological evolution in the field of telecommunications are some of the factors that have led to introduction of telehealth. Browse the full report Telehealth: Market Growth, Future Prospects and Competitive Analysis, 2016-2022 at http://www.credenceresearch.com/report/telehealth-market
Growth in healthcare expenditure, rising trend of home and remote patient care, and increasing awareness about technology assisted healthcare and wellness further ac…

According to the latest report published by Credence Research, Inc. “Non-Invasive Prenatal Testing Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the non-invasive prenatal testing market size was valued at USD 613.0 Mn in 2015, and is expected to reach USD 1,939.9 Mn by 2022, expanding at a CAGR of 17.9% from 2016 to 2022. Market Insights
The global non-invasive prenatal tests (NIPT) market is experiencing a double-digit growth facilitated by market drivers such as rise in average maternity age, growing incidence of chromosomal abnormalities that demand early and non-invasive detection. Other major factor that aids to the growth of this market is rise in healthcare expenditure. Browse the full report Non-Invasive Prenatal Testing: Market Growth, Future Prospects and Competitive Analysis, 2016-2022 at http://www.credenceresearch.com/report/non-invasive-prenatal-testing-market
Non-invasive prenatal testing is defined as a highly sensitive screening process that as…

​The latest market report published by Credence Research, Inc. “Nosocomial Infection Treatment Market Size – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016-2024,” the global nosocomial infection treatment market was valued at US$ 28,565 Mn in 2015, and is expected to reach US$ 36,746 Mn by 2024, expanding at a CAGR of 2.5% from 2016 to 2024. Market Insights
Nosocomial infection, also known as hospital acquired or associated infection (HAI) is defined as an infection developed in patients during the hospital stay that was earlier not present or incubated during admission in the hospital. Nosocomial infection is majorly caused by bacteria, virus, or fungal pathogen and is becoming the leading cause of morbidity and mortality globally, causing enormous economic burden. The nosocomial infection treatment market is anticipated to grow throughout the forecast period. Browse the full report Nosocomial Infection Treatment Market – Growth, Share, Opportunities, Competiti…

​According to the latest report published by Credence Research, Inc. “Treatment Resistant Depression Market: Growth, Future Prospects and Competitive Analysis, 2016-2024,” the treatment resistant depression market size was valued at US$ 863.9 Mn in 2015, and is expected to reach US$ 1,129.1 Mn by 2024, expanding at a CAGR of 3% from 2016 to 2024. Market Insights
Depression is among the most common mental disorders worldwide, affecting approximately 6.7% individuals in the U.S. alone, each year (Anxiety and Depression Association of America). This condition also creates a significant economic burden on the healthcare system. Patients diagnosed with treatment resistant depression has failed two or more antidepressant therapies. Such patients present a critical therapeutic challenge to mental health as this patient group requires specialized TRD management. Browse the full report Treatment Resistant Depression Market: Growth, Future Prospects and Competitive Analysis, 2016-2024 report at …